Novel Sca-1+ macrophages modulate the pathogenic progress of endotoxemia

Min Young Park1, Hyung Sik Kim1, Yu Sun Jeong1

  • 1Department of Biological Sciences, Sungkyunkwan University, Suwon, 16419, Republic of Korea.

Insights

Researchers discovered a new type of macrophage, stem cell antigen-1 (Sca-1)-positive macrophages, during lipopolysaccharide (LPS)-induced inflammation. These Sca-1+ macrophages are less inflammatory and their depletion improves survival in sepsis models.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Macrophages are key innate immune cells involved in inflammation.
  • Macrophage heterogeneity is increasingly recognized based on markers, functions, and location.

Purpose of the Study:

  • To identify and characterize novel macrophage populations in pathological conditions.
  • To investigate the role of stem cell antigen-1 (Sca-1) in macrophage responses to lipopolysaccharide (LPS).

Main Methods:

  • Lipopolysaccharide (LPS) injection in mice.
  • Flow cytometry to detect Sca-1 expression on immune cells.
  • In vivo depletion of Sca-1+ macrophages using anti-Sca-1 antibody.
  • Assessment of inflammatory cytokine production (IL-6, TNF-α, CCL2).
  • Evaluation of survival rates and organ damage in a sepsis model.

Main Results:

  • A novel population of Sca-1-positive macrophages was identified in LPS-induced pathological conditions.
  • Sca-1 upregulation was specific to macrophages, not monocytes or neutrophils, upon LPS exposure.
  • LPS-induced Sca-1+ macrophage generation was partially inhibited by anti-IFN-γ antibody.
  • Sca-1+ macrophages exhibited lower production of IL-6, TNF-α, and CCL2 compared to Sca-1- macrophages.
  • Depletion of Sca-1+ macrophages enhanced survival and reduced organ damage in an LPS-induced sepsis model.

Conclusions:

  • A novel Sca-1+ macrophage population emerges during LPS-induced septic conditions.
  • These Sca-1+ macrophages may play a regulatory role in inflammation, as indicated by reduced cytokine production.
  • Targeting Sca-1+ macrophages presents a potential therapeutic strategy for sepsis.